NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria InfectionsNF135.C10: 통제된 인간 말라리아 감염을 위한 새로운 플라스모디움 팔시파룸 클론Article Published on 2013-02-152024-08-13 Journal: Nanoscale [Category] 말라리아, [키워드] cellular immunology clinical trial Controlled human malaria infection field strain malaria parasite clone parasite culture parasite strain [DOI] 10.1093/infdis/jis725 PMC 바로가기
Plant-derived virus-like particles as vaccinesReview Published on 2013-01-012023-08-30 Journal: Human vaccines & immunotherapeutics [Category] E형 간염, [키워드] cGMP chimeric VLP clinical trial downstream processing glycosylation Oral delivery plant-derived vaccine plant-derived VLP purification Vaccine vaccine platforms virus-like particle (VLP) [DOI] 10.4161/hv.22218 PMC 바로가기 [Article Type] Review
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of ageResearch Paper Published on 2012-09-012023-06-23 Journal: Human vaccines & immunotherapeutics [Category] 신종인플루엔자, [키워드] adjuvant children clinical trial H1N1 immunogenicity Influenza pandemic persistence [DOI] 10.4161/hv.21265 PMC 바로가기 [Article Type] Research Paper
Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos남부 라오스에서 단순한 팔수파룸 말라리아 치료를 위한 국가 추천 아르테미시닌 조합인 아르테메터-루메판트린의 효능Research Published on 2012-06-082024-08-14 Journal: Malaria Journal [Category] 말라리아, [키워드] artemether-lumefantrine Artemisinin-based combination therapy (ACT) clinical trial Coartem Laos malaria Plasmodium falciparum [DOI] 10.1186/1475-2875-11-184 PMC 바로가기 [Article Type] Research
CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral InfectionResearch Article Published on 2012-05-172022-10-29 Journal: PLoS Pathogens [Category] Coronavirus, [키워드] absence Activation administration anti-viral response Author blocker Cancer CD200 clearance clinical trial Control dependent on determine determined different disease disease symptom ENhance Factor female female patient females Host humans Hypothesis IFN immune immune inhibitory immune response immune system immunological impair implication IMPROVE in vitro in vivo Infection influenza A virus Influenza virus inhibit inhibitory inhibitory signal lack Ligand lung MHV mice microbial infection mouse hepatitis neutrophil observé outcome overactive pathogen pathology pathway predict Prevent provided receptor receptors Release reported response Sex Sex difference Signaling supported suppresse therapeutic targeting therapeutic use threshold TLR7 Treatment Type I IFN type I interferon viral clearance viral infection virus virus infection [DOI] 10.1371/journal.ppat.1002710 PMC 바로가기 [Article Type] Research Article
A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis –infected AdultsArticle Published on 2012-04-012024-09-04 Journal: American Journal of Respiratory and Critical Care Medicine [Category] 대상포진, [키워드] clinical trial HIV-1 MVA85A Tuberculosis Vaccine [DOI] 10.1164/rccm.201108-1548OC PMC 바로가기 [Article Type] Article
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Original Article Published on 2011-09-032024-09-04 Journal: Osteoporosis international : a journal established [Category] 대상포진, [키워드] clinical trial Denosumab infections postmenopausal osteoporosis RANKL [DOI] 10.1007/s00198-011-1755-2 PMC 바로가기 [Article Type] Original Article
SARS: Systematic Review of Treatment EffectsResearch Article Published on 2006-09-122022-10-29 Journal: PLoS Medicine [Category] Coronavirus, [키워드] 2003 active against acute respiratory distress acute respiratory syndrome adverse effect affected antiviral drug ARDS Author be applied Blood carried caused CENTRAL China clinical clinical trial clinician conducted Controlled convalescent plasma Corticosteroids cough criteria Culture database death death rate determine disease dosage drug Effect effective Effectiveness Evidence example Fever finding found group had no Health care help helping HIV/AIDS identify IFN IFN type I immune system immunoglobulins In vitro studies in vitro study include inclusion criteria Inconclusive Inflammation information Intravenous immunoglobulin Laboratory life-threatening Lungs MedlinePlus MONITOR NO occurred outbreak Outbreaks Patient patients patients with SARS Pneumonia Potential treatment Protein protocol real time recommendation reduce reduced reported Research researcher review ribavirin Ritonavir SARS patients SARS-CoV SARS-infected patient SARS-infected patients searched severe sneeze Source specific symptom steroid Steroids Symptom syndrome systematic review the WHO tissue treat Treatment Trial Type I IFN type I interferon viral disease virus viruses Web while WHO Wikipedia World Health Organization [DOI] 10.1371/journal.pmed.0030343 PMC 바로가기 [Article Type] Research Article